The gene treatment esophagus cancer the patient lives four more years in last phase

The research which makes use of the gene treatment esophagus cancer appears important breakthrough.Japan thousand leaf the researcher of the university will repress the gene of cancer to inject the surroundings is at the cancer cell, successful control cancer the growth of the cell.10 esophagus cancer which is try patient, thered are 5 people comparing an expectation to much live for 6-12 months, even returned someone to much live above for 4 years.
Esophagus because of close to main artery, so make use of a surgical operation method to move the cancer cell has a high risk, besides which, but Japan thousand leaf university researcher usage new of gene treatment technique, will clean toxic virus to consider as medium together with can repress the gene of growth of the cancer cell, inject cancer cell surroundings, initial result manifestation, this kind of gene therapy can effectively repress cancer cell a growth.
Thousand university professors of leaf who carry on a research point out, "the creation of cancer be a gene development abnormality with the result that, so we think that the treatment gene can cure cancer, we will keep on research gene therapy."


Generally speaking, later period the sufferer of the esophagus cancer mostly lives however a year, but at thousand leafs 10 experiment objects of the university be among them in the middle, had 5 patients to much live for 6-12 months, still had one person to much live for 4 years after treatment, still is continuously accepting a treatment now.
The medical treatment personnel admits that this kind of treatment method will bring a fever etc. side effect, and the gene therapy still studies a stage in the first step, but this discovers brings a silk to hope for the cancer patient.